Article
Brochure
Executive Resource
Insight Hub
Video
Ext. Publication
Home /
Insights & Resources
Insights & Resources
Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.
- Alternative Investments
- Banking
- Blockchain & Digital Assets
- Construction
- Consumer Products
- Energy Transition
- Financial Services
- Food & Beverage
- General Business
- Government
- Health Care
- Higher Education
- Hospitality & Entertainment
- Industrial Products
- Insurance
- Life Sciences
- Not-for-Profit
- Oil & Gas
- Oilfield Services
- Real Estate
- Renewable Fuels
- Technology
- Transportation & Logistics
- Accounting Advisory
- Artificial Intelligence
- Asset Management Consulting
- Asset Tracing
- Cybersecurity
- Data Privacy
- Digital Transformation
- Energy Compliance
- Executive & Leadership Coaching
- Family Law
- Forensics & Litigation
- Government Consulting
- Health Care Valuation
- IT Advisory
- Risk Advisory
- Sustainability Consulting
- Transaction Advisory
- Trust & Estate
- Valuation
Executive ResourceFrom AI and capital markets to cyber and PCAOB focus areas, find summaries and questions for board members on these key topics.
PodcastDiscover when exempt private fund advisers must register with the SEC and explore what steps ensure a smooth, compliant transition.
Private companies can simplify ASC 805 reporting for goodwill and intangibles. Explore ASU 2014-18 and 2014-02 alternatives, eligibility and key tips.
Is your transaction a business combination or asset acquisition? Learn how ASC 805 guidance, the screen test and key differences shape reporting.
Success StoryA medical transportation client needed clarity on true earnings before an acquisition. Weaver guided key decisions, supporting transaction success.
The 2024 Yellow Book updates shift auditors toward a proactive System of Quality Management. Weaver provides insights and tools to help teams adapt.
From AI and capital markets to cyber and PCAOB focus areas, find summaries and questions for board members on these key topics.
Texas life sciences in 2025 saw concentrated capital, declining innovation output and earlier‑stage clinical shifts shaping the ecosystem.
Texas life sciences saw record capital in Q4 2025, even as innovation, early-stage funding and late-phase clinical trials continued to decline.
Learn how AI supports smarter, faster SOX compliance. Weaver’s Second Line Ready series guides you through a disciplined approach and safe execution.
Explore Q3 2025 trends in Texas life sciences, from Series B collapse and pipeline bottlenecks to sector divergence and record late-stage capital.
The IIA’s new Internal Auditing Competency Framework redefines audit credibility. Learn how aligning skills with key risks strengthens business outcomes and governance.
